System and method for metered dosage illumination in a bioanalysis or other system

Information

  • Patent Grant
  • 8389957
  • Patent Number
    8,389,957
  • Date Filed
    Friday, January 14, 2011
    13 years ago
  • Date Issued
    Tuesday, March 5, 2013
    11 years ago
Abstract
A system and method for metered dosage illumination in a bioanalysis or other system. In accordance with an embodiment, an illumination system or subsystem is described that can provide optimized amounts of excitation light within the short exposure times necessary to measure fast biological activity. The amount of light can be precisely measured to provide quantitative results. The light flux can also be precisely controlled to generate only a prescribed minimum amount of light, in order to reduce adverse lighting effects on both fluors and samples. Although the examples herein illustrate the providing of metered dosage illumination in the context of a bioanalysis system, the techniques can be similarly used to provide metered dosage illumination in the context of other types of system.
Description
COPYRIGHT NOTICE

A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.


FIELD OF INVENTION

The invention is generally related to light sources, and bioanalytics or bioanalysis, and is particularly related to a system and method for metered dosage illumination in a bioanalysis or other system.


BACKGROUND

Bioanalytics or bioanalysis is the analysis of biological samples. Bioanalysis systems often use light to excite fluorescence from molecular tags in a sample (referred to herein as fluorescent tags or fluors). Fluors may be exogenous, as in the case of fluorescently labeled immunochemical tags that recognize subcellular structure and bind to impose fluorescent labeling; or endogenous, as in the case of genetically modified cells in which fluorescent proteins for example are expressed in order to impart specific fluorescent signals within a living cell. Particularly in fields such as fluorescence imaging, gene expression analysis, various types of sequencing, high resolution fluorescence microscopy, fluorescence life time measurements, and high content screening, it is necessary to be able to measure the amount of fluorescence and compare that amount to other measurements. This means the excitation light flux must generally be measured for each illumination exposure or fluorescence excitation event. To monitor biological events, it is necessary to be able to measure specific biological activity with often sub-millisecond exposure times. Excitation and detection must occur rapidly, such that the illumination must be generally switched on and off within a time period that is at most one-tenth of the duration of the minimum exposure time. Additionally, fluors can be temporarily or permanently photo-bleached, and biological samples can be otherwise damaged by the illumination light—a process known as phototoxicity. In order to minimize perturbation of the fluors due to photo-bleaching, and photo-damage to the biological samples, it is generally desired to minimize the light flux or dosage within the constraints of the signal-to-noise (S/N) requirements of that particular bioanalysis system. These are the general areas that embodiments of the invention are intended to address.


SUMMARY

Described herein is a system and method for metered dosage illumination in a bioanalysis or other system. In accordance with an embodiment, an illumination system or subsystem is described that can provide optimized amounts of excitation light within the short exposure times necessary to measure fast biological activity. The amount of light can be precisely measured to provide quantitative results. The light flux can also be precisely controlled to generate only a prescribed minimum amount of light, in order to reduce adverse lighting effects on both fluors and samples. Although the examples herein illustrate the providing of metered dosage illumination in the context of a bioanalysis system, the techniques can be similarly used to provide metered dosage illumination in the context of other types of system.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 illustrates a system for metered dosage illumination, in accordance with an embodiment.



FIG. 2 illustrates an example of a graphical user interface (GUI), for use with a system for metered dosage illumination, in accordance with an embodiment.



FIG. 3 illustrates an example of an alternative graphical user interface (GUI), for use with a system for metered dosage illumination, in accordance with an embodiment.



FIG. 4 illustrates an example of a fluorescence lifetime imaging (FLIM) technique, in accordance with an embodiment.



FIG. 5 illustrates an embodiment of an analog measurement of dosage, in accordance with an embodiment.





DETAILED DESCRIPTION

As described above, in the context of bioanalysis, it is often required that an excitation light flux be measured for each illumination exposure or fluorescence excitation event; or that the illumination be switched on and off within an appropriately brief time period; or that the light flux or dosage be minimized within the constraints of the signal-to-noise (S/N) requirements of the particular bioanalysis system.


To address this, described herein is a system and method for metered dosage illumination in a bioanalysis or other system. In accordance with an embodiment, an illumination system or subsystem is described that can provide optimized amounts of excitation light within the short exposure times necessary to measure fast biological activity. The amount of light can be precisely measured to provide quantitative results. The light flux can also be precisely controlled to generate only a prescribed minimum amount of light, in order to reduce adverse lighting effects on both fluors and samples.



FIG. 1 illustrates a system for metered dosage illumination, in accordance with an embodiment. As shown in FIG. 1, in accordance with an embodiment, the system 102 comprises a multi-color light engine 104 that can provide a plurality of different colors of light as a light output 106, to excite various fluorescent markers in a sample 108. An example of such a light engine can be the SPECTRA series of light engines supplied by Lumencor, Inc.


A host computer 110 generates an analysis protocol, including providing a dosage for each of the plurality of colors, and receiving feedback data from a camera 112. In accordance with an embodiment, the dosage can be in the form of a reference count that represents the amount of light flux per exposure period for each color provided by the light engine.


The camera is configured to detect fluorescence from the sample.


A beamsplitter 114 directs a portion of the light engine output, from the light engine, to a photodiode detector 116. A light-to-frequency converter 118 converts the detector output to a pulse train 130, the frequency of which is proportional to the light flux. A microprocessor-based counter 120 counts the pulse train, for each color, and compares the ongoing count to the reference count or preset dosage for each color.


Depending on the particular implementation, the above components can be provided as part of a complete system; or alternatively some or all of the above components can be provided as part of an illumination subsystem. For example, in accordance with an embodiment, the multi-color light engine, beamsplitter, photodiode detector, light-to-frequency converter, and microprocessor-based counter components can be provided as an illumination subsystem intended for use with a separately-provided host computer and camera.


In accordance with an embodiment, during operation of the system, the host computer downloads a reference count 122 for each color to the microprocessor-based counter. For each exposure period, the computer triggers the camera to begin an exposure period 124. The camera then sends an enable message or otherwise enables 126 the light engine, to turn on the appropriate color, and begins integrating the fluorescence. A portion of the light engine output 128, as directed by the beamsplitter, is monitored by the photodiode detector. The detector's output is converted to the pulse train that is then counted by the counter. When the counter reaches the reference count, it disables 132 the color channel currently on or provided by the light engine. Simultaneously, another trigger 134 is sent to the camera, ending the current exposure period.


The above approach avoids the latency inherent in any non-real-time operating systems. In accordance with an embodiment, additional circuitry can be provided to determine which color should be activated, and eliminate any delay inherent in the light engine turning on a color channel. An alternative approach is for the computer to turn on each color directly in conjunction with starting the camera's exposure period. In yet other embodiments, the procedure described above can be modified to suit the particular needs of the system (such as its use in quantitative analyses, or temporally fast analyses, as described below).



FIG. 2 illustrates an example of a graphical user interface (GUI) 142, for use with a system for metered dosage illumination, in accordance with an embodiment. As shown in the example of FIG. 2, the GUI allows an operator to set and to monitor dosage counts in each of the plurality of colors that can be provided by the light engine.



FIG. 3 illustrates an example of an alternative graphical user interface (GUI) 144, for use with a system for metered dosage illumination, in accordance with an embodiment. In the example shown in FIG. 3, the GUI controls power levels and exposure times. For each color channel, the operator can enter the relative power levels, maximum dosage frequency and approximate exposure period. In accordance with an embodiment, the system, or software therein, calculates the required dosage or reference count by multiplying the frequency by the desired exposure time. The exposure time is approximate, since the intensity can change resulting in shorter or longer exposure periods, but still yielding the same metered dosage for each period. If the power level is reduced (for example, by half) the dosimeter frequency is similarly reduced by half assuming a linear response. For the same exposure period the calculated dosage is reduced by half.


Quantitative Analysis


In accordance with an embodiment of particular use in quantitivate analysis, the system can comprise a collection of color channels, wherein each color channel is used to provide the specific wavelength band needed to excite a specific fluorescence molecule as defined by the fluorescence absorption of the tag. In accordance with an embodiment, each color channel can comprise a solid state light source (e.g. an LED, laser, light pipe or other light source), a single band pass filter, and an electronic circuit to power the light source. Within the system, the channels can be combined using, e.g. dichroic mirrors, so that the light from each source travels the same optical path, which is required, e.g. in epifluorescence measurements.


In accordance with an embodiment, the control circuitry can use a photodiode to measure the excitation light flux from each channel during each exposure period. An example of such a photodiode can be the TAOS light-to-frequency converter (part number TSL230RD), which can be used to quantify the light flux or dosage for each illumination pulse. The converter circuit generates pulses at a rate that is proportional to the light flux. Counting the pulses yields a measure of the dosage during each exposure time. Since dosage measurements can be made for each color channel independently, the user can optimize the amount of light, using a GUI such as that described above, to irradiate any given fluor uniquely. This allows for differences in efficiencies of all the processes involved in fluorescent signal generation to be taken into account for each color channel, (e.g. efficiency of light generation, fluorescence generation, or various differences in biological sample condition and fluor concentration).


In accordance with an embodiment, quantitative fluorescent measurements can be obtained ratiometrically by measuring the fluorescent signal, and dividing that signal by the dosage. In this manner, the fluorescent measurements can be normalized and rendered independent of the illumination intensity. This approach can be further automated by using dosage measurements to control the timing of the illumination and detection events. For example in accordance with an embodiment, a desired dosage count for each color channel can be entered into a reference counter. During a measurement, the control electronics monitor the dosage and gate off the excitation source for each color when the dosage count equals the amount in the reference counter. Light is metered independently of the exposure time period, rather as a function of the total light delivery prescribed by the reference counter. The precise dosage is delivered during each exposure, leading to quantitation as precise as the light flux measurement.


In this way, quantitative analysis can be performed using metered dosage with or without constant exposure times. In the former case, the light flux is maintained at the same level, and the flux is delivered within the exposure period. After the metered light dosage has been delivered, the excitation light is gated off leaving a time period when the camera can still detect fluorescent signals. In the latter case, the light flux is held constant, and the exposure time will vary as the intensity fluctuates.


In accordance with an embodiment, a range of light levels can be monitored and measured using conventional counters and logic circuitry. In some instances, the dosage levels may be so small as to generate insufficient statistical counts or too large and can overflow the counters. In these instances, a programmable gain can be used to dynamically adjust the count rate from the dosimeter circuitry.


Temporally Fast Analysis


In accordance with an embodiment of particular use in temporally fast analysis, the sources and circuitry can be implemented for fast switching, as is common with LEDs, lasers and light pipes. For example, in accordance with these embodiments, all switching can be performed electronically, with no mechanical motion. This allows modulation in the range of 10 ns to 1 ms to be readily achieved. In addition, significant speed increases can be achieved by directly connecting the camera and the illumination subsystem. In accordance with this embodiment, the host computer can trigger the camera to begin the analysis. The camera in turn can send a trigger to the illumination subsystem to turn on the excitation light. When the dosage count equals the reference count, the light is gated off, and a signal is sent to the camera to end the exposure. This configuration eliminates the variability in timing associated with non-real-time operating systems.


The illumination subsystem can also be used as a direct connection to drive the camera to activate or advance. Color channels can be programmed, e.g. via a ring buffer, to engage camera operation uniquely for each fluor of interest, each excitation source in a preprogrammed series of exposures of the various color channels. The timing of such camera and/or illuminator pulses can be optimized to interrogate specialized fluor characteristics, such as for fluorophor lifetime measurements, photoactivation and photolysis measurements as examples.


Photo-Bleaching and Phototoxicity


In accordance with another embodiment, the ability to precisely meter the light dosage and precisely turn on and off the illumination can minimize overall the exposure of the biological sample to the illuminator's excitation light. In so doing, photo-bleaching and phototoxicity effects are reduced, sample viability for live cell analyses is prolonged, and artifacts imposed by the lighting on the measurement are reduced. The combined benefit of such dosage optimization is enhanced accuracy and longer duration quantitative fluorescent analyses.


Modulation Techniques


As described above, in accordance with an embodiment, a metered dosage technique can be used to obtain pulse-to-pulse repeatability and increase dynamic range. This technique involves gating the light on and off for the required dosage during each camera exposure period. Other modulation techniques can be used. For example, a modulation technique commonly employed is fluorescence lifetime imaging (FLIM), wherein the illumination is modulated, and the fluorescence lifetime is determined by the phase shift and modulation depth of the fluorescence signal relative to the illumination signal. FIG. 4 illustrates an example of fluorescence lifetime imaging (FLIM) technique 146, in accordance with an embodiment, which is also described at http://www.thorlabs.com/NewGroupPage9.cfm?ObjectGroup_ID=3459; http://en.wikipedia.org/wiki/FLIM; and http://www.lambert-instruments.com/technology_details/1_english/4_technologies/1_flim,_fluorescence_lifetime_imaging_microscopy/7_measurement_methods_flim; http://www.olympusconfocal.com/applications/flimintro.html and http://vvww.microscopyu.com/articles/fluorescence/fret/fretintro.html (Förster Resonance Energy Transfer (FRET) Microscopy), each of which are herein incorporated by reference.


Analog Measurement Techniques


As described above, in accordance with an embodiment, a host computer can be used to generate an analysis protocol, including providing a dosage for each of the plurality of colors, and receiving feedback data from a camera, while a microprocessor-based counter counts the pulse train, and compares the ongoing count to the reference count or preset dosage for each color. in accordance with other embodiments, alternative measurement techniques, such as analog measurement techniques can be used. FIG. 5 illustrates an embodiment 152 which provides an analog measurement of dosage, in accordance with an embodiment. As shown in FIG. 5, the current output of a photodiode (PD) 154 can be fed to a transimpedance amplifier (TIA) 156, and converted to a voltage. This voltage signal can be integrated by the integrator opamp (∫) 158. The comparator (=) 160 compares the integrator output to a target reference level equal to the desired dosage. When the two values are the same, the comparator can generate a signal 162, turning off the light engine.


The present invention may be conveniently implemented using one or more conventional general purpose or specialized digital computers or microprocessors programmed according to the teachings of the present disclosure. Appropriate software coding can readily be prepared by skilled programmers based on the teachings of the present disclosure, as will be apparent to those skilled in the software art.


In some embodiments, the present invention includes a computer program product which is a storage medium (media) having instructions stored thereon/in which can be used to program a computer to perform any of the processes of the present invention. The storage medium can include, but is not limited to, any type of disk including floppy disks, optical discs, DVD, CD-ROMs, microdrive, and magneto-optical disks, ROMs, RAMs, EPROMs, EEPROMs, DRAMs, VRAMs, flash memory devices, magnetic or optical cards, nanosystems (including molecular memory ICs), or any type of media or device suitable for storing instructions and/or data.


The foregoing description of the present invention has been provided for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. In particular, although most of the examples above illustrate the providing of metered dosage illumination in the context of a bioanalysis system, the techniques can be similarly used to provide metered dosage illumination in the context of other types of systems. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application, thereby enabling others skilled in the art to understand the invention for various embodiments and with various modifications that are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the following claims and their equivalence.

Claims
  • 1. A system for providing metered dosage illumination for use in a bioanalysis or other system, comprising: a light engine that can provide a plurality of different colors of light as a light output;a light detector that can detect an indication of light flux at the light output;a light-to-frequency converter that can convert the indication of light flux as detected by the light detector to a pulse train, the frequency of which pulse train is proportional to the light flux;a counter that can compare an ongoing count as indicated by the pulse train, to a preset reference count for a particular color; andwherein, during operation, the illumination system determines a reference count for each color,for an exposure period, enables the light engine to turn on a particular color,monitors the indication of light flux at the light output, as detected by the light detector and converted to the pulse train counted by the counter, andwhen the counter reaches the reference count, disables the particular color currently provided by the light engine, to select a different color.
  • 2. The system of claim 1, wherein the light detector is a photodetector for measuring fluorescence that gates on the illumination, and is gated off when the light-to-frequency count equals the reference count.
  • 3. The system of claim 1, wherein the system triggers on the light detector for quantitative measurements and gates the detector off when the frequency detector count equals a prescribed amount in the reference counter.
  • 4. The system of claim 1, wherein the system further comprises a camera for measuring fluorescence, wherein the system gates on the illumination and is gated off when the light to frequency detector count equals the reference count.
  • 5. The system of claim 1, wherein the system further comprises a camera for imaging and wherein the system gates the camera off when the frequency detector count equals a prescribed amount in the reference counter.
  • 6. The system of claim 1, wherein the system is used as part of a bioanalysis system.
  • 7. The system of claim 6, wherein the system is used for detection of fluorescent tags or fluors in a biological sample.
  • 8. The system of claim 7, wherein the system is used for one or more of quantitative analyses, or temporally fast analyses, such as fluorescence imaging, gene expression analysis, various types of sequencing, high resolution fluorescence microscopy, fluorescence life time measurements, various forms of Förster Resonance Energy Transfer (FRET) Microscopy and high content screening.
  • 9. A method for providing metered dosage illumination for use in a bioanalysis or other system, comprising the steps of: providing a light engine that can provide a plurality of different colors of light as a light output;providing a light detector that can detect an indication of light flux at the light output;providing a light-to-frequency converter that can convert the indication of light flux as detected by the light detector to a pulse train, the frequency of which pulse train is proportional to the light flux;providing a counter that can compare an ongoing count as indicated by the pulse train, to a preset reference count for a particular color; andduring operation of the illumination system determining a reference count for each color,for an exposure period, enabling the light engine to turn on a particular color,monitoring the indication of light flux at the light output, as detected by the light detector and converted to the pulse train counted by the counter, andwhen the counter reaches the reference count, disabling the particular color currently provided by the light engine, to select a different color.
US Referenced Citations (199)
Number Name Date Kind
1998054 McBurney Apr 1935 A
3313337 Bernat Apr 1967 A
3637285 Stewart Jan 1972 A
3759604 Thelen Sep 1973 A
3881800 Friesem May 1975 A
3982151 Ludovici Sep 1976 A
4003080 Maiman Jan 1977 A
4298820 Bongers Nov 1981 A
4371897 Kramer Feb 1983 A
4510555 Mori Apr 1985 A
4539687 Gordon Sep 1985 A
4626068 Caldwell Dec 1986 A
4642695 Iwasaki Feb 1987 A
4644141 Hagen Feb 1987 A
4695332 Gordon Sep 1987 A
4695732 Ward Sep 1987 A
4695762 Berkstresser Sep 1987 A
4713577 Gualtieri Dec 1987 A
4724356 Daehler Feb 1988 A
4798994 Rijpers Jan 1989 A
4804850 Norrish et al. Feb 1989 A
4852985 Fujihara et al. Aug 1989 A
4937661 Van der Voort Jun 1990 A
4995043 Kuwata Feb 1991 A
5052016 Mahbobzadeh Sep 1991 A
5089860 Deppe Feb 1992 A
5109463 Lee Apr 1992 A
5126626 Iwasaki Jun 1992 A
5128846 Mills et al. Jul 1992 A
5137598 Thomas Aug 1992 A
5193015 Shanks Mar 1993 A
5200861 Moskovich Apr 1993 A
5226053 Cho Jul 1993 A
5231533 Gonokami Jul 1993 A
5233372 Matsumoto Aug 1993 A
5249195 Feldman Sep 1993 A
5285131 Muller Feb 1994 A
5289018 Okuda Feb 1994 A
5312535 Waska May 1994 A
5315128 Hunt May 1994 A
5332892 Li et al. Jul 1994 A
5345333 Greenberg Sep 1994 A
5363398 Glass Nov 1994 A
5416342 Edmond et al. May 1995 A
5416617 Loiseaux May 1995 A
5418584 Larson May 1995 A
5428476 Jensen Jun 1995 A
5469018 Jacobsen Nov 1995 A
5475281 Heijboer Dec 1995 A
5478658 Dodabalapur Dec 1995 A
5489771 Beach et al. Feb 1996 A
5493177 Muller Feb 1996 A
5500569 Blomberg Mar 1996 A
5542016 Kaschke Jul 1996 A
5616986 Jacobsen Apr 1997 A
5644676 Blomberg Jul 1997 A
5658976 Carpenter Aug 1997 A
5669692 Thorgersen Sep 1997 A
5671050 De Groot Sep 1997 A
5674698 Zarling Oct 1997 A
5690417 Polidor et al. Nov 1997 A
5715083 Takayama Feb 1998 A
5719391 Kain Feb 1998 A
5757014 Bruno May 1998 A
5781338 Kapitza Jul 1998 A
5803579 Turnbull et al. Sep 1998 A
5804919 Jacobsen Sep 1998 A
5808759 Okamori Sep 1998 A
5827438 Blomberg Oct 1998 A
5833827 Anazawa Nov 1998 A
5858562 Utsugi Jan 1999 A
5864426 Songer Jan 1999 A
5942319 Oyama Aug 1999 A
5955839 Jaffe Sep 1999 A
5984861 Crowley Nov 1999 A
6110106 MacKinnon et al. Aug 2000 A
6154282 Lilge et al. Nov 2000 A
6198211 Jaffe Mar 2001 B1
6204971 Morris Mar 2001 B1
6222673 Austin Apr 2001 B1
6293911 Imaizumi et al. Sep 2001 B1
6299338 Levinson Oct 2001 B1
6304584 Krupke Oct 2001 B1
6366383 Roeder Apr 2002 B1
6392341 Jacobsen May 2002 B2
6404127 Jacobsen Jun 2002 B2
6404495 Melman Jun 2002 B1
6422994 Kaneko et al. Jul 2002 B1
6444476 Morgan Sep 2002 B1
6513962 Mayshack et al. Feb 2003 B1
6517213 Fujita et al. Feb 2003 B1
6529322 Jones Mar 2003 B1
6542231 Garrett Apr 2003 B1
6544734 Briscoe Apr 2003 B1
6594075 Kanao et al. Jul 2003 B1
6608332 Shimizu et al. Aug 2003 B2
6614161 Jacobsen Sep 2003 B1
6614179 Shimizu et al. Sep 2003 B1
6637905 Ng Oct 2003 B1
6642652 Collins Nov 2003 B2
6649432 Eilers Nov 2003 B1
6674575 Tandler et al. Jan 2004 B1
6680569 Mueller-Mach et al. Jan 2004 B2
6685341 Ouderkirk et al. Feb 2004 B2
6690467 Reel Feb 2004 B1
6717353 Mueller Apr 2004 B1
6747710 Hall Jun 2004 B2
6791259 Stokes et al. Sep 2004 B1
6791629 Moskovich Sep 2004 B2
6795239 Tandler Sep 2004 B2
6843590 Jones Jan 2005 B2
6869206 Zimmerman et al. Mar 2005 B2
6870165 Amirkhanian Mar 2005 B2
6926848 Le Mercier Aug 2005 B2
6958245 Seul et al. Oct 2005 B2
6960872 Beeson et al. Nov 2005 B2
6981970 Karni Jan 2006 B2
6991358 Kokogawa Jan 2006 B2
6995355 Rains, Jr. et al. Feb 2006 B2
7009211 Eilers Mar 2006 B2
7011421 Hulse et al. Mar 2006 B2
7035017 Tadic-Galeb Apr 2006 B2
7083610 Murray et al. Aug 2006 B1
7153015 Brukilacchio Dec 2006 B2
7192161 Cleaver et al. Mar 2007 B1
7205048 Naasani Apr 2007 B2
7208007 Nightingale et al. Apr 2007 B2
7211833 Slater, Jr. et al. May 2007 B2
7239449 Leitel et al. Jul 2007 B2
7300175 Brukilacchio Nov 2007 B2
7316497 Rutherford et al. Jan 2008 B2
7384797 Blair Jun 2008 B1
7416313 Westphal et al. Aug 2008 B2
7422356 Hama et al. Sep 2008 B2
7427146 Conner Sep 2008 B2
7445340 Conner Nov 2008 B2
7467885 Grotsch et al. Dec 2008 B2
7488088 Brukilacchio Feb 2009 B2
7488101 Brukilacchio Feb 2009 B2
7498734 Suehiro et al. Mar 2009 B2
7540616 Conner Jun 2009 B2
7633093 Blonder et al. Dec 2009 B2
7709811 Conner May 2010 B2
7746560 Yamazaki Jun 2010 B2
7832878 Brukilacchio Nov 2010 B2
7837348 Narendran et al. Nov 2010 B2
7854514 Conner Dec 2010 B2
7857457 Rutherford et al. Dec 2010 B2
8029142 Conner Oct 2011 B2
20010055208 Kimura Dec 2001 A1
20020109844 Christel et al. Aug 2002 A1
20020127224 Chen Sep 2002 A1
20030044160 Jones et al. Mar 2003 A1
20030095401 Hanson et al. May 2003 A1
20030127609 El-Hage Jul 2003 A1
20030160151 Zarate Aug 2003 A1
20030230728 Dai Dec 2003 A1
20030233138 Spooner Dec 2003 A1
20040090600 Blei May 2004 A1
20040247861 Naasani Dec 2004 A1
20050062404 Jones et al. Mar 2005 A1
20050116635 Walson et al. Jun 2005 A1
20050146652 Yokoyama et al. Jul 2005 A1
20050152029 Endo Jul 2005 A1
20050184651 Cheng Aug 2005 A1
20050201899 Weisbuch Sep 2005 A1
20050248839 Yamaguchi Nov 2005 A1
20050260676 Chandler Nov 2005 A1
20050263679 Fan Dec 2005 A1
20060002131 Schultz et al. Jan 2006 A1
20060030026 Garcia Feb 2006 A1
20060060872 Edmond Mar 2006 A1
20060060879 Edmond Mar 2006 A1
20060114960 Snee Jun 2006 A1
20060170931 Guo Aug 2006 A1
20060237658 Waluszko Oct 2006 A1
20060282137 Nightingale et al. Dec 2006 A1
20070053184 Brukilacchio Mar 2007 A1
20070053200 Brukilacchio Mar 2007 A1
20070058389 Brukilacchio Mar 2007 A1
20070064202 Moffat et al. Mar 2007 A1
20070086006 Ebersole et al. Apr 2007 A1
20070126017 Krames et al. Jun 2007 A1
20070211460 Ravkin Sep 2007 A1
20070253733 Fey Nov 2007 A1
20070262731 Jaffar et al. Nov 2007 A1
20070279914 Rutherford et al. Dec 2007 A1
20070279915 Rutherford et al. Dec 2007 A1
20070280622 Rutherford et al. Dec 2007 A1
20070281322 Jaffe et al. Dec 2007 A1
20070284513 Fan Dec 2007 A1
20070297049 Schadwinkel et al. Dec 2007 A1
20080079910 Rutherford et al. Apr 2008 A1
20080224024 Ashdown Sep 2008 A1
20080291446 Smith Nov 2008 A1
20090122533 Brukilacchio May 2009 A1
20090196046 Rutherford et al. Aug 2009 A1
20090268461 Deak et al. Oct 2009 A1
20100188017 Brukilacchio Jul 2010 A1
Foreign Referenced Citations (13)
Number Date Country
2 280 398 Apr 2000 CA
1 426 807 Dec 2003 EP
0943756 Dec 1963 GB
2005-195485 Jul 2005 JP
2005-243973 Sep 2005 JP
2006-049814 Feb 2006 JP
2007-133435 May 2007 JP
2008139796 Jun 2008 JP
10-2006-0055934 May 2006 KR
WO 02080577 Oct 2002 WO
WO 2004114053 Dec 2004 WO
WO 2006067885 Jun 2006 WO
WO 2006120586 Nov 2006 WO
Non-Patent Literature Citations (37)
Entry
Deck, L., et al., “Two color light-emitting-diode source for high precision phase-shifting interferometry”, Optics Letters, vol. 18, No. 22, Nov. 15, 1993, pp. 1899-1901.
Morgan, C. G., et al., << New Approaches to Lifetime-Resolved Luminescence Imaging, Journal of Fluorescence, vol. 7, No. 1, 1997, pp. 65-73.
International Search Report dated Jun. 19, 2012 for Application No. PCT/US2011/063030, 11 pages.
International Search Report dated Dec. 31, 2008, Application No. PCT/US2008/072394, 10 pages.
International Search Report for PCT/US2010021843 dated Aug. 19, 2010, 9 pages.
Extended European Search Report for PCT/US2008072394 dated Oct. 7, 2011, 9 pages.
Mauch, R.H., et al., “Optical Behaviour of Electroluminescent Devices,” Springer Proceedings in Physics, vol. 38, Electroluminescence, © Springer-Verlag Berlin, Heidelberg, pp. 291-295 (1989).
Vlasenko, N.A., et al., “Interference of Luminescent Emission from an Evaporated Phosphor,” Opt. Spect., vol. 11, pp. 216-219 (1961).
Vlasenko, N.A., et al., “Investigation of Interference Effects in Thin Electroluminescent ZnS-Mn Films,” Opt. Spect., vol. 28, pp. 68-71 (1970).
Poelman, D., et al., “Spectral Shifts in Thin Film Electroluminescent Devices: An Interference Effect,” J. Phys. D: Appl. Phys., vol. 25, pp. 1010-1013 (1992).
Tuenge, R.T., “Current Status of Color TFEL Phosphors,” Electroluminescence—Proceedings of the Sixth International Workshop on Electroluminescence, El Paso, Tex., pp. 173-177, May 1992.
Plasma Display Manufacturers of the American Display Consortium, “Recommended Research Topics on Plasma Display for the DARPA Sponsored Phosphor Center of Excellence,” pp. 1-2, Mar. 24, 1993.
Yamamoto, Y., et al., “Optical Processes in Microcavities,” Physics Today, pp. 66-73, Jun. 1993.
E.F. Schubert, E.F., et al., “Giant Enhancement of Luminescence Intensity in Er-doped Si/SiO2 Resonant Cavities,” Appl. Phys. Lett. vol. 61, No. 12, pp. 1381-1383, Sep. 21, 1992.
Yokoyama, H., “Physics and Device Applications of Optical Microcavities,” Science, vol. 256, pp. 66-70, Apr. 3, 1992.
Haroche, S., et al., “Cavity Quantum Electrodynamics,” Scientific American, pp. 54-62, Apr. 1993.
Depp, S.W., et al., “Flat Panel Displays,” Scientific American, pp. 90-97, Mar. 1993.
Huo, D.T.C., et al., “Reticulated Single-Crystal Luminescent Screen,” J. Electrochem. Soc., vol. 133, No. 7, pp. 1492-1497, Jul. 1986.
Hinds, E.A., “Spectroscopy of Atoms in a Micron-Sized Cavity,” (date and periodical title unknown), pp. 18-19.
Whitaker, Jerry C., “Electronic Displays: Technology, Design, and Applications,” McGraw-Hill, Inc., pp. 185-192 (1994).
Hecht, Jeff, “Diverse fiberoptic systems require varied sources,” Laser Focus World, vol. 36, No. 1, pp. 155-161, Jan. 2000.
Hamberg, I. and Granqvist, C.G., “Evaporated Sn-doped In2O3 films: Basic optical properties and applications to energy-efficient windows,” Journal of Applied Physics, vol. 60, No. 11, pp. R123-R159, Dec. 1, 1986.
World Watch, Photonics Spectra, “IR Reflective Coating Boosts Bulb's Output, Recycling of IR Energy Saves Power, Cuts Costs” pp. 40-41, Jan. 1991.
Jenmar Visual Systems, Sunnyvale, CA, 4 pages, no date, but at least as early as Oct. 15, 1998.
DDS™ Rear Projection Screens, LORS™ Reflection Screens, © 1998 Physical Optics Corporation, Torrance, CA, 2 pages.
Schott Glass Technologies, Inc., Schott Total Customer Care, Contrast Enhancement Filters, Duryea, PA, 6 pages, Jan. 1998.
Handbook of Optics, vol. 1—Fundamentals, Techniques, and Design, Second Edition, Chapter 42: Optical Properties of Films and Coatings, J.A. Dobrowolski, pp. 42.3-42.25, McGraw-Hill, Inc., © 1995.
Young, L., “Multilayer Interference Filters with Narrow Stop Bands,” Applied Optics, vol. 6, No. 2, pp. 297-312, Feb. 1967.
Hemingway, D.J. and Lissberger, P.H., “Effective Refractive Indices of Metal-Dielectric Interference Filters,” Applied Optics, vol. 6, No. 3, pp. 471-476, Mar. 1967.
Holloway, R.J. and Lissberger, P.H., “The Design and Preparation of Induced Transmission Filters,” Applied Optics, vol. 8, No. 3, pp. 653-660, Mar. 1969.
Landau, B.V. and Lissberger, P.H., “Theory of Induced-Transmission Filters in Terms of the Concept of Equivalent Layers,” Journal of the Optical Society of America, vol. 62, No. 11, pp. 1258-1264, Nov. 1972.
Lissberger, P.H., “Coatings with Induced Transmission,” Applied Optics, vol. 20, No. 1, pp. 95-103, Jan. 1, 1981.
Pelletier, E. and MacLeod, H.A., “Interference Filters with Multiple Peaks,” Journal of the Optical Society of America, vol. 72, No. 6, pp. 683-687, Jun. 1982.
Da-Lite Screen Company, Inc., www,da-lite,com, 46 pages website downloads as of Oct. 8, 1998.
Stewart Filmscreen Corporation®, www.stewartfilm.com, 34 pages website downloads as of Oct. 8, 1998.
Albrecht, M., et al., “Scintillators and Wavelength Shifters for the Detection of Ionizing Radiation,” Astroparticle, Particle and Space Physics, Detectors and Medical Physics Applications, ICATPP-8, M. Barone, et al., Eds, World Scientific, pp. 502-511 (2004).
Flor-Henry, M., et al., “Use of a Highly Sensitive Two-Dimensional Luminescence Imaging System to Monitor Endogenous Bioluminescence in Plant Leaves,” BMC Plant Biology, vol. 4, No. 19, Nov. 2004.
Related Publications (1)
Number Date Country
20120181936 A1 Jul 2012 US